Correlation Between Revelation Biosciences and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Revelation Biosciences and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and LMF Acquisition.
Diversification Opportunities for Revelation Biosciences and LMF Acquisition
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Revelation and LMF is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and LMF Acquisition go up and down completely randomly.
Pair Corralation between Revelation Biosciences and LMF Acquisition
Assuming the 90 days horizon Revelation Biosciences is expected to generate 4.0 times more return on investment than LMF Acquisition. However, Revelation Biosciences is 4.0 times more volatile than LMF Acquisition Opportunities. It trades about 0.08 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about 0.06 per unit of risk. If you would invest 1.85 in Revelation Biosciences on August 28, 2024 and sell it today you would lose (0.62) from holding Revelation Biosciences or give up 33.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 96.61% |
| Values | Daily Returns |
Revelation Biosciences vs. LMF Acquisition Opportunities
Performance |
| Timeline |
| Revelation Biosciences |
| LMF Acquisition Oppo |
Revelation Biosciences and LMF Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and LMF Acquisition
The main advantage of trading using opposite Revelation Biosciences and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.| Revelation Biosciences vs. Revelation Biosciences | Revelation Biosciences vs. SAB Biotherapeutics | Revelation Biosciences vs. Jasper Therapeutics | Revelation Biosciences vs. Thayer Ventures Acquisition |
| LMF Acquisition vs. Eliem Therapeutics | LMF Acquisition vs. Scpharmaceuticals | LMF Acquisition vs. Milestone Pharmaceuticals | LMF Acquisition vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |